for subcutaneous injection. clinical trials

A phase II clinical trial to evaluate the safety, efficacy, and pharmacokinetics of RBD1016 injection in participants with chronic hepatitis B

This study is testing a new medicine, RBD1016, for chronic hepatitis B. We want to see how safe it is, how well it works to lower the virus, and how the body uses it. This is an early-stage study to gather important information.